To identify whether high amounts of tumor antigens contribute to the robust NKG2A/CD94 expression in tumor‐specific Tex cells, we firstly delineate the NKG2A/CD94+ tumor‐specific P14 cells in the tumor and peripheral lymphoid tissues of B16F10‐GP‐engrafted recipients. The gene discussed is KLRD1; the disease is neoplasm.